Research shows weight loss surgery can help reduce the risk of severe liver problems for some patients with MASH.

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...

Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic ...

A recent study found that 80% of Indian IT professionals have fatty liver due to a sedentary lifestyle, poor diet, and work ...

1 With the introduction of the first ever drugs to treat metabolic dysfunction-associated steatohepatitis (MASH), such as Rezdiffra (resmetirom), an alternative to liver biopsy is essential. Liver ...

1 With the introduction of the first ever drugs to treat metabolic dysfunction-associated steatohepatitis (MASH ... is a spectrum of liver diseases where there is excess fat in the liver (steatosis).

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

The liver is the body’s chemical factory, where most metabolic processes take place. It processes everything you eat and drink, converting them into energy and essential nutrients. Additionally, the ...

The farnesoid X receptor (FXR) is a bile acid nuclear receptor that plays a crucial role in regulating bile acid and sterol metabolism.